See more : Power Master II Holdings. Co., Ltd. (6839.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Kindly MD, Inc. (KDLY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kindly MD, Inc., a leading company in the Medical – Equipment & Services industry within the Healthcare sector.
- NRGene Technologies Ltd (NRGN.TA) Income Statement Analysis – Financial Results
- Intellinetics, Inc. (INLX) Income Statement Analysis – Financial Results
- Agilysys, Inc. (AGYS) Income Statement Analysis – Financial Results
- Affluent Foundation Holdings Limited (1757.HK) Income Statement Analysis – Financial Results
- Trelleborg AB (publ) (TREL-B.ST) Income Statement Analysis – Financial Results
Kindly MD, Inc. (KDLY)
About Kindly MD, Inc.
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 3.77M | 3.79M | 2.50M |
| Cost of Revenue | 3.93M | 4.38M | 1.59M |
| Gross Profit | -158.54K | -595.30K | 914.92K |
| Gross Profit Ratio | -4.21% | -15.72% | 36.53% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.36M | 6.27M | 2.36M |
| Selling & Marketing | 0.00 | -4.18M | -1.50M |
| SG&A | 1.36M | 2.10M | 853.58K |
| Other Expenses | 105.64K | 152.82K | 88.00K |
| Operating Expenses | 1.36M | 2.10M | 853.58K |
| Cost & Expenses | 5.39M | 6.48M | 2.44M |
| Interest Income | 0.00 | 0.00 | 0.00 |
| Interest Expense | 55.84K | 0.00 | 0.00 |
| Depreciation & Amortization | 203.22K | 122.01K | 63.40K |
| EBITDA | -1.36M | -2.42M | 66.20K |
| EBITDA Ratio | -36.05% | -67.90% | 4.98% |
| Operating Income | -1.62M | -2.69M | 61.34K |
| Operating Income Ratio | -42.99% | -71.12% | 2.45% |
| Total Other Income/Expenses | 2.76K | 152.82K | 88.00K |
| Income Before Tax | -1.62M | -2.54M | 149.34K |
| Income Before Tax Ratio | -42.92% | -67.09% | 5.96% |
| Income Tax Expense | 0.00 | 5.00 | 3.00 |
| Net Income | -1.62M | -2.54M | 149.34K |
| Net Income Ratio | -42.92% | -67.09% | 5.96% |
| EPS | -0.27 | -0.43 | 0.03 |
| EPS Diluted | -0.27 | -0.43 | 0.03 |
| Weighted Avg Shares Out | 5.97M | 5.97M | 5.97M |
| Weighted Avg Shares Out (Dil) | 5.97M | 5.97M | 5.97M |
KindlyMD(R) Announces Third Quarter 2024 Financial Results
KindlyMD(R) Announces New Partnership With Cigna Healthcare to Further Expand Patient Care Accessibility
KindlyMD(TM) Recognized with Healthcare AI Impact Award 2024
KindlyMD(TM) Appoints Nancy Pratt as Behavioral Health Program Director
KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update
KindlyMD to Present at Upcoming August 2024 Investor Conferences
KindlyMD(TM) Submits Comment to the Department of Justice Regarding Cannabis Rescheduling
3 Cannabis Stocks to Buy at a 52-Week Low in July
3 IPO Gems Flying Under the Radar (for Now)
KindlyMD(TM) is Proudly Contracted with Blue Cross Blue Shield Under Utah's Top Insurance Payors
Source: https://incomestatements.info
Category: Stock Reports